newsfilter
← Latest News
PR Newswire·

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

  • Novavax, Inc. will report its first quarter 2026 financial results & operational highlights on May 6, 2026.
  • The conference call is scheduled for 8:30 a.m. ET on May 6, 2026.
  • Registration for the call is available at ir.novavax.com/events.
  • U.S. dial-in number for the live call is (888) 880-3330; international number is (+1) (646) 357-8766.
  • Participants may request an automated callback by registering online or join via an operator by dialing directly.
  • A replay of the call will be available from 11:30 a.m. ET on May 6, 2026, until 11:59 p.m. ET on May 13, 2026.
  • Replay dial-in numbers are (800) 770-2030 (U.S.) or (+1) (609) 800-9909 (International) with passcode 1309751#.
  • The webcast replay will remain accessible at ir.novavax.com/events until June 6, 2026.
  • Novavax focuses on vaccine technology including its Matrix-M adjuvant & protein-based nanoparticles.
  • Investor contact is Jim Kelly at 844-668-2829; media contact is Yvonne Sprow at 844-264-8571.